{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:21:01Z","timestamp":1782296461036,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrep.2026.102598","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T14:59:32Z","timestamp":1776524372000},"page":"102598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Oroxylin A ameliorates hepatic steatosis and non-alcoholic fatty liver disease through the regulation of CPT1A m6A methylation in hepatocytes"],"prefix":"10.1016","volume":"46","author":[{"given":"Yihong","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9767-6730","authenticated-orcid":false,"given":"Jinlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-3518","authenticated-orcid":false,"given":"Lin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bbrep.2026.102598_bib1","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bbrep.2026.102598_bib2","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/apt.17362","article-title":"Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease","volume":"57","author":"Liu","year":"2023","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102598_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrep.2026.102598_bib4","article-title":"Unveiling p65 as the target of diphyllin in ameliorating metabolic dysfunction-associated steatotic liver disease via targeted protein degradation technology","volume":"16","author":"Zhu","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.bbrep.2026.102598_bib5","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbrep.2026.102598_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113936","article-title":"Inhibition of ZFP281\/ZNF281-RIPK1\/RIPK3\/MLKL signaling in hepatocytes by pterostilbene relieves hepatic lipometabolic disorder and inflammation in non-alcoholic steatohepatitis","volume":"146","author":"Lu","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"21","key":"10.1016\/j.bbrep.2026.102598_bib7","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102598_bib8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/1535370214547123","article-title":"Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1 c pathway","volume":"240","author":"Lee","year":"2015","journal-title":"Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102598_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3892\/ijmm.2015.2074","article-title":"Puerarin ameliorates hepatic steatosis by activating the PPAR\u03b1 and AMPK signaling pathways in hepatocytes","volume":"35","author":"Kang","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102598_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12964-019-0324-8","article-title":"Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells","volume":"17","author":"Wang","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrep.2026.102598_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2020.03.031","article-title":"Oroxylin a promotes PGC-1\u03b1\/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease","volume":"153","author":"Kai","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrep.2026.102598_bib12","article-title":"Antidepressant-like activity of oroxylin A in mice models of depression: a behavioral and neurobiological characterization","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102598_bib13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"J. Hepatol."},{"issue":"18","key":"10.1016\/j.bbrep.2026.102598_bib14","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.bbrep.2026.102598_bib15","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.3390\/biomedicines11123280","article-title":"SREBP regulation of lipid metabolism in liver disease, and therapeutic strategies","volume":"11","author":"Li","year":"2023","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.bbrep.2026.102598_bib16","doi-asserted-by":"crossref","first-page":"bqz046","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102598_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102598_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102598_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/17425247.2025.2466767","article-title":"GalNac-siRNA conjugate delivery technology promotes the treatment of typical chronic liver diseases","volume":"22","author":"Qin","year":"2025","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.bbrep.2026.102598_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2025.159628","article-title":"Oroxylin A ameliorates non-alcoholic fatty liver disease by modulating oxidative stress and ferroptosis through the Nrf2 pathway","author":"Jiang","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102598_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.livres.2023.11.003","article-title":"In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: mechanism and pharmacological interventions","volume":"7","author":"Zhu","year":"2023","journal-title":"Liver Res."},{"issue":"6477","key":"10.1016\/j.bbrep.2026.102598_bib22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.aay6018","article-title":"N 6-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription","volume":"367","author":"Liu","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.bbrep.2026.102598_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102211","article-title":"Interplay of RNA m(6)A modification-related geneset in pan-cancer","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomedicines"},{"issue":"7608","key":"10.1016\/j.bbrep.2026.102598_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature18298","article-title":"Structural basis of N 6-adenosine methylation by the METTL3\u2013METTL14 complex","volume":"534","author":"Wang","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbrep.2026.102598_bib25","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ymthe.2021.09.016","article-title":"METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease","volume":"30","author":"Peng","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102598_bib26","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1038\/s41598-025-90419-z","article-title":"METTL3 promotes the progression of non-alcoholic fatty liver disease by mediating m6A methylation of FAS","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:42:01Z","timestamp":1781739721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"alternative-id":["S2405580826001585"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102598","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oroxylin A ameliorates hepatic steatosis and non-alcoholic fatty liver disease through the regulation of CPT1A m6A methylation in hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102598"}}